biote Corp. cotiza a 1.14 USD y tiene una capitalización bursátil de $33M. En los últimos 12 meses ha facturado $184M con un margen de flujo de caja libre del 15.7%. Cotiza a 1.6 veces su flujo de caja libre (P/FCF) y a un PER de 5.6. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-e…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-03 |
|---|---|---|---|---|
| Real | — | $0.04 | $0.08 | $0.07 |
| Estimado | $0.04 | $0.03 | $0.08 | $0.10 |
| Sorpresa | — | +33.3% | +0.0% | -30.0% |
| Métrica | BTMD | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 71.5% | 57.0% | +14.4% |
| Operating Margin | 18.5% | -38.6% | +57.1% |
| Net Margin | 14.1% | -33.6% | +47.6% |
| FCF Margin | 15.7% | -13.9% | +29.6% |
| ROE | — | -40.4% | — |
| ROA | 25.1% | -32.0% | +57.1% |
| Current Ratio | 1.22 | 2.84 | -1.62 |
| Debt / Equity | -1.76 | 0.28 | -2.04 |